Available Genomic Tests for Clinically Localized Prostate Cancer

A review of the currently available genomic testing options for patients with clinically localized prostate cancer and the NCCN and AUA/ASTRO recommendations based on risk group.

Related Videos
Ricardo M. de Oliveira Soares, MD, answers a question during a Zoom video interview
Dr. Adam Murphy in an interview with Urology Times
Expert cardiologist
Expert urologist
Expert cardiologist
Expert urologist
Patient predictors of postprostatectomy incontinence | Image credit: © jakkapan - stock.adobe.com
Related Content
© 2023 MJH Life Sciences

All rights reserved.